Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: Incidence, onset time and risk factors

Bone Marrow Transplantation

Volumn 22, Issue 12, 1998, Pages 1191-1197

  Hasegawa, S ^a   Horibe, K ^a   Kawabe, T ^a   Kato, K ^b   Kojima, S ^b   Matsuyama, T ^b   Hirabayashi, N ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

Author keywords

Bone marrow transplantation (BMT); Children; Late onset; Risk factor; Veno occlusive disease (VOD)

Indexed keywords

CHOLINESTERASE; FOSFOMYCIN; MINOCYCLINE; SERUM ALBUMIN;

ADOLESCENT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; BLOOD DISEASE; CHILD; CHILDHOOD DISEASE; CHOLINESTERASE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; HISTOLOGY; HLA MATCHING; HUMAN; INFANT; LIVER VENOOCCLUSIVE DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; RISK FACTOR; TIME;

EID: 0032440852     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701506     Document Type: Article

References (26)

1. Jones RJ, Lee KSK, Beschorner WE et al. Venoocclusive disease of the liver following bone marrow transplantation. Transplantation 1987; 44: 778-783.
2. Shulman HM, Gown AM, Nugent DJ. Hepatic veno-occlusive disease after bone marrow transplantation: immunohistochemical identification of the material within occluded central venules. Am J Pathol 1987; 127: 549-558.
3. Rollins BJ. Hepatic veno-occlusive disease. Am J Med 1986; 81: 297-305.
4. McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow transplantation: diagnosis, incidence, and predisposing factors. Hepatology 1984; 4: 116-122.
5. McDonald GB, Hinds MS, Fisher LD et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Am Intern Med 1993; 118: 255-267.
6. Bearman SI. The syndrome of hepatic veno-occlusive disease after marrow transplantation. Blood 1995; 85: 3005-3020.
7. Ganem G, Saint-Marc Giradin M-F, Kuentz M et al. Ven-occlusive disease of the liver after allogeneic bone marrow transplantation in man. Int J Rad Oncol Biol Phys 1988; 14: 879-884.
8. Brugieres L, Hartmann O, Benhamou E et al. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome. Bone Marrow Transplant 1988; 3: 53-58.
9. Meresse V, Hartmann O, Vassal G et al. Risk factors for hepatic venoocclusive disease after high-dose busulfan-containing regimens followed by autologous bone marrow transplantation: a study in 136 children. Bone Marrow Transplant 1992; 10: 135-141.
10. Ayash LJ, Hunt M, Antman K et al. Hepatic venoocclusive disease in autologous bone marrow transplantation of solid tumors and lymphomas. J Clin Oncol 1990; 8: 1699-1706.
11. Locasciulli A, Bacigalupo A, Alberti A et al. Predictability before transplant of hepatic complications following allogeneic bone marrow transplantation. Transplantation 1989; 48: 68-72.
12. Morgan M, Dodds A, Atkinson K et al. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529-534.
13. Copelan EA, Biggs JC, Thompson JM et al. Treatment for acute myelocytic leukemia with allogeneic bone marrow transplantation following preparation with BuCy2. Blood 1991; 78: 838-843.
14. Biggs JC, Szer J, Crilley P et al. Treatment of chronic myeloid leukemia with allogeneic bone marrow transplantation after preparation with BuCy2. Blood 1992; 80: 1352-1357.
15. Ringden O, Ruutu T, Remberger M et al. A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group. Blood 1994; 83: 2723-2730.
16. Kurokawa S, Hirabayashi N, Kodera Y et al. Veno-occlusive disease following allogeneic bone marrow transplantation. Acta Hepatol Jpn 1991; 32: 717-723.
17. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after bone marrow transplantation for leukemia. New Engl J Med 1986; 314: 729-735.
18. Brinbaum ZW. Computers and unconventional test statistics. In: Proschan F, Serfling RJ (eds). Reliability and Biometry. Society of Applied Mathematics: Philadelphia, 1974, pp 441-458.
19. Blostein MD, Paltiel OB, Thibault A, Rybka WB. A comparison of clinical criteria for the diagnosis of veno-occlusive disease of the liver after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 439-443.
20. Rozman C, Carreras E, Qian C et al. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia. Bone Marrow Transplant 1996; 17: 75-80.
21. Ozkaynak MF, Weinberg K, Kohn D et al. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome. Bone Marrow Transplant 1991; 7: 467-474.
22. Kami M, Mori S, Tanikawa S et al. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution. Bone Marrow Transplant 1997; 20: 397-402.
23. Soiffer RJ, Dear K, Rabinowe SN et al. Hepatic dysfunction following T-cell-depleted allogeneic bone marrow transplantation. Transplantation 1991; 52: 1014-1019.
24. Morikawa K, Watabe H, Araake M, Morikawa S. Modulatory effect of antibiotics on cytokine production by human monocytes in vitro. Antimicrob Agents Chemother 1996; 40: 1366-1370.
25. Holler E, Kolb HJ, Moller A et al. Increased serum levels of tumor necrosis factor α precede major complications of bone marrow transplantation. Blood 1990; 75: 1011-1016.
26. Shulman HM, Hinterberger W. Hepatic veno-occlusive disease - liver toxicity syndrome after bone marrow transplantation. Bone Marrow Transplant 1992; 10: 197-214.